PK Study in Adolescents and Young Adults Treated with Glucocorticoids

Update Il y a 4 ans
Reference: EUCTR2012-003414-14

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

-To assess the safety and tolerability of single doses of odanacatib in mature adolescents. -To compare plasma pharmacokinetic parameters [AUC0-∞, AUC0-168hr, Cmax, C168hr, Tmax, apparent terminal t½] following a single oral dose of odanacatib 10 mg (Panel A) between mature adolescents and adult historical controls and 50 mg (Panel B) between mature adolescents and young adults (Panel C).


Inclusion criteria

  • Osteoporosis